Annals of Diagnostic Pathology
Volume 12, Issue 6 , Pages 426-429 , December 2008

Atypical mycobacteriosis of the larynx: an unusual clinical presentation secondary to steroids inhalation

  • Beverly Y. Wang, MD

      Affiliations

    • Department of Pathology, Tisch Hospital, H461, New York University Medical Center, NY 10016, USA
    • Corresponding Author InformationCorresponding author.
  • ,
  • May Jennifer Amolat, MD

      Affiliations

    • Department of Pathology, Mount Sinai Medical Center, NY 10029, USA
  • ,
  • Peak Woo, MD

      Affiliations

    • Department of Otolaryngology, Mount Sinai Medical Center, NY 10029, USA
  • ,
  • Margaret Brandwein-Gensler, MD

      Affiliations

    • Department of Pathology, Albert Einstein Medical School, Montefiore Hospital, Bronx NY 10461, USA

References 

  1. Koch M, Rabinowitsch I. Die Tuberculose der Vogel und Ihre Beziehungen zur Sangertiertuberculose. Virchows Arch Pathol Anat. 1907;190–246
  2. Chapman JS. The atypical mycobacteria and human mycobacteriosis. vol 16. New York: Plenum Medical; 1977;
  3. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979;119:107–159
  4. Meissner G, Anz W. Sources of Mycobacterium avium complex infection resulting in human diseases. Am Rev Respir Dis. 1977;116:1057–1064
  5. Parker BC, Ford MA, Gruft H, Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria: IV. Preferential aerosolization of Mycobacterium intracellulare from natural waters. Am Rev Respir Dis. 1983;128:652–656
  6. Horsburgh CRJ, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis. 1989;139:4–7
  7. Bermudez LE, Young LS. Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complex. Infect Immun. 1994;62:2021–2026
  8. Havlir DV, Ellner JJ. Mycobacterium avium complex. In:  Mandell H editors. Principles and practice of infectious diseases. 5th ed. New York: Churchill Livingston; 2000;p. 2617–2627
  9. Delap TG, Lavy JA, Alusi G, Quiney RE. Tuberculosis presenting as a laryngeal tumour. J Infect. 1997;34:139–141
  10. Rubin AM, Brondbo K, Alberti PW, et al. Head and neck manifestations of mycobacteria in the absence of pulmonary disease. J Otolaryngol. 1982;11:385–390
  11. Bernat Gili A, Morais Perez D, Ayerbe Torrero V, Baena Arevalo A, Fernandez Liesa R. Retropharyngeal abscess due to atypical mycobacteria. Case report. An Otorrinolaringol Ibero Am. 1993;20:225–234
  12. Ogawa T, Iizuka M, Chiba Y, Fukuda Y, Takahara Y. Study of atypical mycobacterium. Six experiments on the isolation of mycobacteria and atypical mycobacteria isolated from laryngeal mucus treated with 1 per cent NaOH. Rinsho Byori. 1968;16:223–227
  13. McEwan JA, Mohsen AH, Schmid ML, McKendrick MW. A hoarse voice: atypical mycobacterial infection of the larynx. J Laryngol Otol. 2001;115:920–922
  14. Qiu L, Brandwein MS, Woo P, Gil J, Wang BY. Sclerosing sarcoidosis of larynx. Arch Otolaryngol Head Neck Surg. 2004;130:115–116
  15. Lebovics RS, Hoffman GS, Leavitt RY, Kerr GS, Travis WD, Kammerer W, et al. The management of subglottic stenosis in patients with Wegener's granulomatosis. Laryngoscope. 1992;102:1341–1345
  16. Kandiloros DC, Nikolopoulos TP, Ferekidis EA, et al. Laryngeal tuberculosis at the end of the 20th century. J Laryngol Otol. 1997;111:619–621
  17. Fairfax AJ, David V, Douce G. Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma. Thorax. 1999;54:860–861
  18. DelGaudio JM. Steroid inhaler laryngitis: dysphonia caused by inhaled fluticasone therapy. Arch Otolaryngol Head Neck Surg. 2002;128:677–681
  19. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999;159:941–955

PII: S1092-9134(07)00060-3

doi: 10.1016/j.anndiagpath.2007.04.011

Annals of Diagnostic Pathology
Volume 12, Issue 6 , Pages 426-429 , December 2008